Research programme: amyotrophic lateral sclerosis vaccine - Amarna Therapeutics/TreewayAlternative Names: Amyotrophic lateral sclerosis gene therapy vaccine - Amarna Therapeutics/Treeway; TW-003
Latest Information Update: 02 Dec 2015
At a glance
- Originator Treeway
- Developer Amarna Therapeutics; Treeway
- Class Gene therapies; Vaccines
- Mechanism of Action Gene transference; Immunomodulators
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Research Amyotrophic lateral sclerosis